Life Sciences Moves Fast. This is Where it Meets.
The DIA Global Annual Meeting is where life sciences professionals from industry, regulatory agencies, patients, and academia come together to drive breakthroughs in healthcare — advancing science, policy, and patient outcomes worldwide.
Register NowThe Neutral Ground the Industry Needs
No single sector can solve what's ahead alone. DIA brings together industry, regulators, academia, and patient advocates to work through the hardest problems in medical product development together. From early discovery to post-market surveillance, the full therapeutic lifecycle is in the room.
DIA 2027 Highlights
Breaking Down Silos
Connect with stakeholders across industry, regulatory agencies, academia, and patient advocacy to tackle complex challenges together.
View AgendaA Global Conversation With Local Impact
With participants from over 40 countries, DIA 2027 is where international regulatory harmonization, global market strategy, and cross-border collaboration happen in real time, with direct implications for how you work when you get home.
Explore Our OfferingsGlobal Annual Meeting Through the Years
The energy, the connections, the moments that stay with you long after you leave.
The Evolution of DIA
Sixty-three years ago, thirty people saw a problem the industry couldn't solve alone. They built the table. We're still at it.
DIA Is Founded
In the wake of the Thalidomide crisis, 30 pharmaceutical professionals, medical writers, and academics recognized that the industry needed a neutral place to work through its hardest problems together. DIA was built to be that place, and has been ever since.
Global Expansion
DIA enters a period of global growth and expansion to support ICH and the scientific evaluation of medicines efforts, establishing formal offices in the US, Switzerland, and Japan. DIA members form a Community to define global data standards used in medical research, which leads to the formation of the Clinical Data Interchange Standards Consortium (CDISC).
Global Membership Growth
DIA membership expands globally to over 80 countries, with local offerings to Latin America, Canada, Korea, China, India, the Middle East and Singapore. DIA relaunches Drug Information Journal as Therapeutic Innovation & Regulatory Science.
DIA Reimagined for the Future
DIA 2027 represents the next evolution—enhanced learning formats, expanded networking, and innovative programming like the LIFT Series, while maintaining the power of in-person connection.
Publications & Science at DIA
Share Evidence. Shape Dialogue.
Publish peer-reviewed research, expert perspectives, and practical insights through DIA's publications portfolio — connecting your work to the conversations that matter most in medical product development.
Explore PublicationsRead What's Shaping the Conversation
Explore expert perspectives and peer-reviewed research on AI, obesity, clinical trials, cell & gene therapy, regulatory innovation, and more — the topics driving the agenda at GAM 2027.
Featured ArticlesFrom Evidence to Impact
See how peer-reviewed research, expert perspectives, and collaborative scientific initiatives in chronic diseases, AI, cell & gene therapy, precision medicine, and other high-priority areas drive the conversations — and solutions — featured at GAM 2027.
Explore Our InitiativesSan Diego is Waiting
Be in the room where the future of medical product development gets decided. June 28–July 1, 2027
Register for DIA 2027